Cai, H., Li, X., Li, J., Ao, L., Yan, H., Tong, M., . . . Guo, Z. (2015). Tamoxifen therapy benefit predictive signature coupled with prognostic signature of post-operative recurrent risk for early stage ER+ breast cancer. Oncotarget.

Cai, Hao, Xiangyu Li, Jing Li, Lu Ao, Haidan Yan, Mengsha Tong, Qingzhou Guan, Mengyao Li, and Zheng Guo. "Tamoxifen Therapy Benefit Predictive Signature Coupled With Prognostic Signature of Post-operative Recurrent Risk for Early Stage ER+ Breast Cancer." Oncotarget 2015.

Cai, Hao, et al. "Tamoxifen Therapy Benefit Predictive Signature Coupled With Prognostic Signature of Post-operative Recurrent Risk for Early Stage ER+ Breast Cancer." Oncotarget 2015.